Today: 9 June 2026
Unilever stock rises in London as banks slide, investors lean defensive
12 January 2026
1 min read

Unilever stock rises in London as banks slide, investors lean defensive

London, Jan 12, 2026, 08:55 GMT — Regular session

Unilever PLC (ULVR.L) shares climbed 0.8% to 4,783.5 pence by 0840 GMT, settling near the day’s high after closing Friday at 4,744 pence. The stock’s 52-week range stands between 4,123 pence and 4,930 pence, data showed.

European stocks opened cautiously, dragged lower by a drop in bank shares. By 0807 GMT, the STOXX 600 was down 0.2%, with banks tumbling 1.1%. The sell-off followed U.S. President Donald Trump’s announcement of a one-year cap on credit card interest rates at 10%, effective Jan. 20. Barclays (BARC.L) led losses, sliding 4.5%, while HSBC (HSBA.L) dipped about 1%.

Traders continued to weigh new strains on the U.S. Federal Reserve, boosting appetite for safer bets and more stable earnings. “Trump is pulling at the loose threads of central bank independence,” noted Andrew Lilley, chief rates strategist at Barrenjoey. S&P 500 futures dropped 0.5%, while gold climbed above $4,600 an ounce, according to the Reuters report. Reuters

Unilever’s focus now shifts to upcoming numbers following its ice cream spin-off, which changed the landscape. In a Jan. 8 pre-close aide-mémoire, the company reaffirmed its 2025 outlook for underlying sales growth—organic growth excluding currency effects and acquisitions—at 3% to 5%. It also expects second-half underlying operating margin to hit at least 19.5%. Fourth-quarter underlying volume growth should match or exceed the 1.7% seen in Q3, the memo added. Ice Cream will be classified as a discontinued operation in the Q4 and full-year 2025 results, after the demerger finalized on Dec. 6. Unilever’s shares were consolidated at an 8-for-9 ratio on Dec. 9. The company holds roughly a 19.9% stake in The Magnum Ice Cream Company for up to five years.

This is key for the stock as investors scramble to define what “normal” volume and margin levels will be for the remaining businesses after ice cream earnings fall away. A clear separation aids comparisons, but it also cuts loose a familiar benchmark from previous quarters.

The main takeaway for February will probably be the tug-of-war between volume and price. Volume tracks how much product actually sold. Price reflects what the company charged — and markets have quickly penalized staples firms when pricing stayed firm but consumers opted for cheaper options.

That defensive demand could evaporate quickly if risk appetite returns and investors shift back to cyclicals. Unilever’s upcoming results might also spook the market if they suggest volume-driven growth is losing steam amid normalizing prices. Currency fluctuations remain a wildcard for this global company, which operates across numerous markets and reports using a blend of local costs and revenues.

Unilever plans to release its Q4 and full-year 2025 earnings on Feb. 12.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update
Previous Story

Babcock (BAB.L) share price edges toward 52-week high as traders line up for Jan 26 update

National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L
Next Story

National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L

Go toTop